Your browser doesn't support javascript.
loading
[The efficacy and safety of Bruton tyrosine kinase inhibitors as monotherapy in the treatment of newly diagnosed patients with Waldenström macroglobulinemia].
Tao, Y; Xu, Y L; Wang, S; Wang, L; Zhao, W L.
Afiliação
  • Tao Y; Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.
  • Xu YL; Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.
  • Wang S; Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.
  • Wang L; Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.
  • Zhao WL; Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.
Zhonghua Xue Ye Xue Za Zhi ; 44(6): 490-494, 2023 Jun 14.
Article em Zh | MEDLINE | ID: mdl-37550205

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Macroglobulinemia de Waldenstrom Tipo de estudo: Diagnostic_studies / Observational_studies / Risk_factors_studies Limite: Humans País/Região como assunto: Asia Idioma: Zh Revista: Zhonghua Xue Ye Xue Za Zhi Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Macroglobulinemia de Waldenstrom Tipo de estudo: Diagnostic_studies / Observational_studies / Risk_factors_studies Limite: Humans País/Região como assunto: Asia Idioma: Zh Revista: Zhonghua Xue Ye Xue Za Zhi Ano de publicação: 2023 Tipo de documento: Article